Or maybe just Versea. Funny you didn't like the idea of Versea going public when I posted it way back on another board. How on earth could anyone acquire AXIM with all those notes out there allowing the insiders to incrementally take the company private. The same cast of characters rode NPTX into the ground rather than giving up their notes and push options.
I am The Blue Skys - Everything Else is Just Weather
My posts are for entertainment purposes and are not Investment Advice
Recent PFSA News
- Profusa Announces Listing Transfer to The Nasdaq Capital Market • GlobeNewswire Inc. • 05/15/2026 11:30:00 AM
- Profusa Receives Favorable Nasdaq Listing Determination • GlobeNewswire Inc. • 05/08/2026 10:00:00 AM
- Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value • GlobeNewswire Inc. • 05/05/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/05/2026 04:15:23 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/04/2026 03:55:55 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/01/2026 07:28:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 09:30:22 PM
- Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform • GlobeNewswire Inc. • 04/06/2026 10:00:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/02/2026 02:10:43 PM
- Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering • GlobeNewswire Inc. • 02/27/2026 02:15:00 PM
- Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance • GlobeNewswire Inc. • 02/19/2026 01:30:00 PM
- Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies • GlobeNewswire Inc. • 02/13/2026 01:30:00 PM
- Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies • GlobeNewswire Inc. • 02/12/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 01:00:47 PM
- Profusa Announces 1-for-75 Reverse Stock Split • GlobeNewswire Inc. • 02/05/2026 01:00:00 PM
- Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026 • GlobeNewswire Inc. • 01/29/2026 01:00:00 PM
- Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue • GlobeNewswire Inc. • 01/16/2026 12:30:00 PM
- Profusa Adds Leading Greek Vascular Surgeon to Customer Base • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Profusa Bolsters European Commercial Network with New French Distributor, MedSell • GlobeNewswire Inc. • 12/31/2025 12:30:00 PM
- Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 • GlobeNewswire Inc. • 12/30/2025 12:30:00 PM
- Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 • GlobeNewswire Inc. • 12/11/2025 01:30:00 PM
- Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025 • GlobeNewswire Inc. • 11/24/2025 01:15:00 PM
- Profusa Announces Third Quarter Business and Financial Highlights • GlobeNewswire Inc. • 11/19/2025 10:44:52 PM
